DR. AGARWAL'S EYE HOSP L Valuation
DRAGARWQ · Healthcare · Current price ₹5,360
Is DR. AGARWAL'S EYE HOSP L undervalued?
DocStoX estimates the fair value of DR. AGARWAL'S EYE HOSP L at ₹2,694 per share, versus the current market price of ₹5,360. That puts the stock about -49.7% above our fair-value estimate, which we read as "Avoid". Our confidence in this estimate is low.
How this fair value is calculated
This estimate blends 4 independent methods: Residual income (₹577), Relative P/E (₹9,384), Graham floor (₹1,204), Analyst target (₹600). We weight each by its reliability and skip any method whose inputs look untrustworthy — "no DCF beats a wrong DCF". This is the same deterministic engine that powers DocStoX stock pages; there is no guesswork or AI-generated number here.
Bear, base and bull scenarios
Our scenarios span ₹577 (bear) to ₹2,694 (base) to ₹9,384 (bull). A margin of safety means buying meaningfully below the base case — the wider the gap, the more room for error in the assumptions.
Valuation multiples
DR. AGARWAL'S EYE HOSP L trades at a P/E of 46.1x and a P/B of 7.2x, with a dividend yield of 0.1%. Multiples are most useful compared against the company's own history and its sector peers — see the peer comparison for context.
Understand the ratios
More on DR. AGARWAL'S EYE HOSP L
DocStoX estimates are generated by a deterministic valuation engine from reported financials — for informational purposes only, not investment advice. Consult a SEBI-registered advisor before investing.